Model
Edge
Revance Therapeutics Inc.
0001803375
Filing Type
4
Filing Date
2/1/2024
Updated
2/2/24, 9:48 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership